Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Collagenase clostridium histolyticum (Xiapex) for thumb and first web space Dupuytren contractures
2012-000516-28Phase 4Active
- Sponsor
- University Medical Center Groningen
- Start
- May 2012
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of collagenase clostridium histolyticum in Dupuytren's contracture, sponsored by University Medical Center Groningen. Primary endpoint: Reduction in extension deficit. Started May 2012; status: active.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Dupuytren's contracture
Beyond the preview
Go deeper on 2012-000516-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000516-28.